ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours

British Journal of Cancer

Volumn 106, Issue 3, 2012, Pages 562-568

  Karger, S ^a   Krause, K ^a   Gutknecht, M ^a   Schierle, K ^a   Graf, D ^b   Steinert, F ^c   Dralle, H ^d   Fuhrer D ^e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Private Practice of Endocrinology and Nuclear Medicine   (Germany)

^c Helios Clinic Schkeuditz   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Thyroid tumours; molecular markers; fine needle aspiration biopsy

Indexed keywords

MOLECULAR MARKER; THYROGLOBULIN;

ADENOMATOUS NODULE; ADM3 GENE; ARTICLE; ASPIRATION BIOPSY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FOLLICULAR ADENOMA; FOLLICULAR THYROID CANCER; GENE; GENE EXPRESSION; HGD1 GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LGALS3 GENE; MAJOR CLINICAL STUDY; MARKER GENE; MOLECULAR DIAGNOSIS; PAPILLARY THYROID CANCER; PLAB GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TFF3 GENE; THYROID CANCER; THYROID NODULE; THYROID SURGERY; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; GALECTIN 3; HUMANS; PEPTIDES; PREDICTIVE VALUE OF TESTS; THYROID NEOPLASMS; THYROID NODULE;

EID: 84856503288     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.578     Document Type: Article

References (32)

1. Baloch ZW, Livolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, Demay RM, Sidawy MK, Frable WJ (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36: 425-437 (Pubitemid 351829800)
2. Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK (1998) Fine-needle aspiration of thyroid: an institutional experience. Thyroid 8: 565-569 (Pubitemid 28354907)
3. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O, Thyroid Cancer Study Group (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357: 1644-1650 (Pubitemid 32568236)
4. Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ (2004) A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 113: 1234-1242 (Pubitemid 38544109)
5. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL (2001) Analysis of ret/ PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 86: 2187-2190 (Pubitemid 32472938)
6. Chudova D, Wilde JI, Wang ET, Wang H, Rabbee N, Egidio CM, Reynolds J, Tom E, Pagan M, Rigl CT, Friedman L, Wang CC, Lanman RB, Zeiger M, Kebebew E, Rosai J, Fellegara G, LiVolsi VA, Kennedy GC (2010) Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 95: 5296-5304
7. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. IARC Press: Lyon, pp 49-133
8. Ducena K, Abols A, Vilmanis J, Narbuts Z, Circrs J, Rçjeva D, Line A, Pirags V (2011) Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules. Thyroid Res 4: 11
9. Eszlinger M, Krohn K, Berger K, Lauter J, Kropf S, Beck M, Fuhrer D, Paschke R (2005) Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab 90: 1163-1170 (Pubitemid 40279249)
10. Eszlinger M, Krohn K, Kukulska A, Jarzab B, Paschke R (2007) Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors. Endocr Rev 28: 322-338 (Pubitemid 46984830)
11. Fuhrer D, Eszlinger M, Karger S, Krause K, Engelhardt C, Hasenclever D, Dralle H, Paschke R (2005) Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur J Endocrinol 152: 785-790 (Pubitemid 40744548)
12. Gharib H (2004) Changing trends in thyroid practice: understanding nodular thyroid disease. Endocr Pract 10: 31-39
13. Hamberger B, Gharib H, Melton III LJ, Goellner JR, Zinsmeister AR (1982) Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 73: 381-384 (Pubitemid 12031790)
14. Hegedüs L (2010) Can elastography stretch our understanding of thyroid histomorphology? J Clin Endocrinol Metab 95: 5213-5215
15. Hegedüs L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24: 102-132 (Pubitemid 36223282)
16. Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, Dominquez M (2009) An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 94: 1748-1751
17. Jacques C, Baris O, Prunier-Mirebeau D, Savagner F, Rodien P, Rohmer V, Franc B, Guyetant S, Malthiery Y, Reynier P (2005) Twostep differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J Clin Endocrinol Metab 90: 2314-2320 (Pubitemid 40586279)
18. Krause K, Eszlinger M, Gimm O, Karger S, Engelhardt C, Dralle H, Führer D (2008) TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency. J Clin Endocrinol Metab 93: 1390-1393 (Pubitemid 351519738)
19. Lubitz CC, Ugras SK, Kazam JJ, Zhu B, Scognamiglio T, Chen YT, Fahey III TJ (2006) Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn 8: 490-498 (Pubitemid 44377932)
20. Nikiforov YE (2011) Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med 135: 569-577
21. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN (2009) Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94: 2092-2098
22. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608 (Pubitemid 351656494)
23. Patel MR, Stadler ME, Deal AM, Kim HS, Shores CG, Zanation AM (2011) STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates. Laryngoscope 121: 983-989
24. Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C (2007) Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid 17: 1109-1115 (Pubitemid 350207747)
25. Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L, Basolo F, Santoro M (2004) Analysis of BRAF point mutation and RET/PTC rearrangements refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89: 5175-5180 (Pubitemid 39391466)
26. Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M, Motta M, Troncone G, Caleo A, Vallefuoco P, Rossi G, Fenzi G, Vitale M (2007) Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fineneedle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer 14: 1089-1097 (Pubitemid 351252440)
27. Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, Lee JE, Evans DB (2003) Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg 186: 702-710 (Pubitemid 37522110)
28. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Liu G, Higashiyama T, Morita S, Kuma K, Amino N (1998) Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res 58: 4913-4917 (Pubitemid 28503690)
29. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2004) Highthroughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer 90: 1600-1605 (Pubitemid 38648245)
30. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2005) Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Cancer Lett 219: 91-96 (Pubitemid 40203175)
31. Wang DY, Fulthorpe R, Liss SN, Edwards EA (2004) Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol 18: 402-411 (Pubitemid 38183938)
32. Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C (2005) Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 90: 2512-2521 (Pubitemid 40686285)